
Organometallics p. 2937 - 2950 (1995)
Update date:2022-08-05
Topics:
Chetcuti, Michael J.
Grant, Brian E.
Fanwick, Philip E.
The reactions of disubstituted alkynes with the mixed-metal complexes NiCp*M(CO)3Cp (1, M = Mo, W) are presented, and the chemistry of the resultant products is developed. Complexes 1 react with nonterminal alkynes to afford nickelacyclic products of the type NiCp*{μ-η2(1,3-Ni), η2(1,2-M)-C(R)C(R′)C(O)}M(CO)2Cp″ (3) [M = Mo, W; R = R′ = Me; R = Me, R′ = Ph. Cp″ = Cp, Cp′; not all combinations made]. Complexes 3 may be thermally decarbonylated to the μ-alkyne (dimetallatetrahedrane) complexes NiCp*(μ-η2,η2-RC 2R′)M(CO)2-Cp″ (2). Complex 3a (R = R′ = Me; M = Mo; Cp″ = Cp) may be protonated or alkylated at the metallacyclic acyl-like carbonyl ligand with HBF4·Et2O or R3O+BF4- (R = Me, Et), respectively, to afford the cationic species [NiCp*{μ-η2(1,3-Mo),η 2(1,2-Ni)-C(Me)C(Me)C(OH)}-Mo(CO)2Cp]+BF 4- (4, Ni-Mo) and [NiCP*{μ-η2(1,3-Mo),η 2(1,2-Ni)-C(Me)C(Me)C(OR)}Mo(CO)2-Cp]+ BF4- (Ni-Mo; 5a, R = Me; 5b, R = Et), respectively. On the basis of an analysis of the 13C NMR spectrum of 5c′, a Ni-W analog of 5a, complexes 4 and 5 are believed to contain molybdenacycle, not nickelacycle, rings - i.e. a ring flip takes place during the protonation or the alkylation reaction. The attempted substitution of a carbonyl ligand in 5a with tBuNC in the presense of the oxidant Me3NO led to oxidation at the molybdenum center, loss of all carbonyl ligands, rupture of the Ni-Mo bond, and insertion of an isocyanide ligand into one of the Mo-C σ-bonds. The structure of the resulting cationic molybdenum oxo species 7, NiCp*{μ-η3(1,2,3-Ni)-C(OMe)C(Me)C(Me)C(N tBu)}Mo(O)Cp+BF4- was established by an X-ray diffraction study. Crystal data for 7, NiMoC26H38BF4NO2: monoclinic, P21/c (No. 14), a = 12.288(3) A?, b = 13.130(2) A?, c = 17.013(4) A?, β = 93.47 (1)°, Z = 4, R(F) = 0.042, and RW(F) = 0.051. Complex 5a reacts with KHBEt3 affording what is believed to be the hydridoacyl species NiCp*{μ-η3(1,2,3-Ni),η 2(1,4-Mo)-C(OMe)C(Me)C(Me)C(O)}MoH(CO)Cp (8, Ni-Mo). A carbonyl ligand in 5a may be substituted with an iodide ion to afford the neutral molybdenum iodo species NiCp*{μ-η3-(Ni),η 2(1,3-Mo)-C(Me)C(Me)C(OMe)}MoI(CO)Cp (9, Ni-Mo). Alkylation of 9 with MeLi afforded the very air-sensitive Mo-Me complex NiCp*{μ η3-(Ni),η2(1,3-Mo)-C(Me)C(Me)C(OMe)}MoMe(CO)Cp (10, Ni-Mo).
Jinan Hongfangde Pharmatech Co.LTD
Contact:0531-88870908
Address:F Bldg,750#,Shunhua Rd,New&High-tech Zone,Jinan,Shandong,China 250101
Chengda Pharmaceuticals Co., Ltd.
Contact:+86-573-84601188
Address:hengshan Road 5# in Jiashan, zhejiang
Shaanxi HuaTai Bio-fine chemical company Ltd
Contact:86-029-87862197
Address:No. 5, 3rd Floor, 29 Yanta North Road, Beilin Dist.
Fujian Huitian Biological Pharmacy Co., Ltd.
Contact:0086-598-8300831; 8339920
Address:No.46,Taijiang Road,Sanming City,Fujian,China
JIANGXI AIFEIMU TECHNOLOGY CO.,LTD
Contact:+86-570-6040289
Address:FINECHEMICAL PARK,ZIBU TOWN,WANNIAN COUNTY,JIANGXI PROV.,CHINA,ZIP
Doi:10.1021/ja01031a023
(1969)Doi:10.1021/jm00017a016
(1995)Doi:10.1016/S0040-4039(00)99073-7
(1985)Doi:10.1016/0957-4166(95)00144-E
(1995)Doi:10.1021/jo00121a047
(1995)Doi:10.1021/ic00126a012
(1995)